Public Release: 

Vital exhaustion may raise risk of first-time cardiovascular disease

Abstract 17412 (Hall A2, Core 2)

American Heart Association

Fatigue, increased irritability and feeling demoralized -- a combination known as vital exhaustion -- may raise the risk of first-time cardiovascular disease in otherwise healthy men and women, according to research presented at the American Heart Association's Scientific Sessions 2014.

Researchers examined the relationship between vital exhaustion and first-time heart disease in 11 prospective studies that involved more than 60,000 people without heart disease. The studies had an average six and half years of follow-up.

After adjusting for other factors, researchers observed a 36 percent increased risk of developing first-time cardiovascular disease from vital exhaustion.

"Vital exhaustion is a significant risk factor for incident cardiovascular disease in healthy subjects, comparable to some of the other psychological risk factors for cardiac disease," researchers said.

###

Randy Cohen, M.D., cardiologist, Mt. Sinai St. Luke's-Roosevelt Hospital Center, New York, New York

Additional Resources:

  • Available multimedia resources (photos/videos/graphics) are available on the right column of the release link http://newsroom.heart.org/news/monday-news-tips-2775523?preview=e69ad8189b77c70b1f24d047b63fcf17
  • For more news from AHA's Scientific Sessions, follow us on Twitter @HeartNews #AHA14

    Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.

    For Media Inquiries:

    AHA News Media in Dallas: (214) 706-1173

    AHA News Media Office, Nov. 15-19,

    at the McCormick Place Convention Center: (312) 949-3400

    For Public Inquiries: (800) AHA-USA1 (242-8721)

    heart.org and strokeassociation.org

    Life is why we fund scientific breakthroughs that save and improve lives.

  • Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.